ID   KMS-11/Cfz
AC   CVCL_IQ84
DR   cancercelllines; CVCL_IQ84
DR   GEO; GSM1692587
DR   GEO; GSM1692588
DR   GEO; GSM1692589
DR   Wikidata; Q54900166
RX   PubMed=26109433;
CC   Population: Japanese.
CC   Characteristics: Produces IgG kappa.
CC   Selected for resistance to: ChEBI; CHEBI:65347; Carfilzomib (Kyprolis; PX-171-007).
CC   Sequence variation: Gene fusion; HGNC; 5722; IGKJ4 + HGNC; 5739; IGKV1-37; Name(s)=IGKV1-37-IGKJ4 (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; 5723; IGKJ5 + HGNC; 5816; IGKV3-15; Name(s)=IGKV3-15-IGKJ5 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; 3690; FGFR3; Simple; p.Tyr373Cys (c.1118A>G); ClinVar=VCV000016342; Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; 12033; TRAF3; Simple; p.Lys191Leufs*3; Zygosity=Homozygous (from parent cell line).
CC   Omics: Transcriptome analysis by microarray.
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C3242; Plasma cell myeloma
DI   ORDO; Orphanet_29073; Multiple myeloma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_2989 ! KMS-11
SX   Female
AG   67Y
CA   Cancer cell line
DT   Created: 03-03-17; Last updated: 05-10-23; Version: 10
//
RX   PubMed=26109433; DOI=10.18632/oncotarget.4530;
RA   Riz I., Hawley T.S., Hawley R.G.;
RT   "KLF4-SQSTM1/p62-associated prosurvival autophagy contributes to
RT   carfilzomib resistance in multiple myeloma models.";
RL   Oncotarget 6:14814-14831(2015).
//